The United States is the worlds largest investor in health at a global scalefunding and implementing programs to address challenges, including global health security, HIV and other infectious diseases, women and child health, non-communicable diseases, vaccine and drug development, digital health, and global health governance. Although Congress appropriates funding, these efforts are largely carried out by departments and agencies in the executive branch, and the new Administration has already signaled a dramatic reduction in foreign aid.
Join Dr. Mike Merson, Professor Lia Fernald, and Dean Stefano M. Bertozzi for a discussion of the future of the countrys commitment to improving human health worldwide. How can we maintain effective investments in global health initiatives in a rapidly changing environment?
Michael H. Merson MD joined the Duke University faculty in 2006 and is the founding director of the Duke Global Health Institute. In 2011, he was named the vice president and vice provost for global affairs at Duke University. Dr. Merson served as the director of the World Health Organizations Diarrheal Diseases Control Program for almost a decade. In 1990, he was appointed as director of the WHO Global Program on AIDS, coordinating the global response to the HIV/AIDS pandemic. He has served in advisory capacities for UNAIDS, WHO, the Global Fund to Fight AIDS, TB and Malaria, World Bank, Doris Duke Foundation, World Economic Forum, and the Bill & Melinda Gates Foundation, and is an elected member of the National Academy of Medicine.
This talk is part of the 2016-2017 UC Berkeley School of Public Health Deans Speaker Series.
Alumni, Faculty, General Public, Staff, Students - Graduate, Students - Undergraduate